CC
AMLX icon

Centiva Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

Centiva Capital’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,464
Closed -$291K – 1081
2025
Q2 		$291K Buy
45,464
+17,242
+61% +$83.9K 0.02% 1201
2025
Q1 		$99.9K Sell
28,222
-5,609
-17% -$20K 0.01% 1398
2024
Q4 		$128K Buy
+33,831
New +$159K ﹤0.01% 1455
2024
Q3 		– Sell
-90,733
Closed -$172K – 2103
2024
Q2 		$172K Buy
+90,733
New +$176K 0.01% 1730
2024
Q1 		– Sell
-19,188
Closed -$282K – 1743
2023
Q4 		$282K Buy
+19,188
New +$294K 0.02% 1234

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return